Copy the short URL in each article and paste it new tab
Monday, November 23, 2015
Breakingviews: Pfizer-Allergan's D.C. snub
Antony Currie and Rob Cox explain how the $160 bln pharma merger gets around recent U.S. attempts to stop inversion deals – and why it may prompt policymakers to reform the tax code.
from Reuters Video: Breakingviews http://ift.tt/1X9C4KD
via IFTTT
No comments:
Post a Comment